Dxb asx

Dimerix Limited. Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs.

Dimerix develops and commercialises patient preferred pharmaceutical products for global markets using innovative receptor technology to identify and develop drugs in areas with an unmet need. Nina has over twenty five years of experience in the pharmaceutical industry, with leadership roles in investor relations, business development, and prosecution of intellectual property matters, as well as leading and managing the strategic, scientific and operational aspects of product development. Nina holds a Ph. Sonia is currently Executive Manager at AC Immune, a Nasdaq listed company, and has previously worked within Swiss Stock Exchange listed companies Hoffman la Roche and Addex Therapeutics, where she has held leadership and executive positions across various disciplines in drug discovery, pre-clinical development and translational science and has interacted with regulatory authorities, investors and public funding institutions. She has broad knowledge of small molecule drug design, optimisation and early clinical development, with expertise which encompasses multiple therapeutic areas. Sonia is co-author of more than 50 scientific papers and several patents.

Dxb asx

Looks you are already a member. Please enter your password to proceed. Forgotten password? Click here. Please make sure your payment details are up to date to continue your membership. Please contact Member Services on support investsmart. It may take a few minutes to update your subscription details, during this time you will not be able to view locked content. If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in. Registration for this event is available only to Eureka Report members. View our membership page for more information. Registration for this event is available only to Intelligent Investor members.

Having trouble renewing? Those wanting to exit a stock and holding out for newsflow or a liquidity event are probably getting to the point where time is running out, dxb asx. Date set for DXB clinical trial result [Jul].

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board. Corporate governance.

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board. Corporate governance. Media centre. ASX rulebooks.

Dxb asx

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets. Show more Opinion link Opinion. Show more Personal Finance link Personal Finance.

No water signs in chart

Unsubscribe whenever your want. Remember me. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement in respect of Australian products or Investment Statement in respect of New Zealand products before making any decision to invest. Load More. Here we are, the final two weeks of June tax-loss selling. First name is required. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Those wanting to exit a stock and holding out for newsflow or a liquidity event are probably getting to the point where time is running out. Morning Update. In this feature, we look at why some small cap share prices surge upwards despite bear market conditions. Code of practice. Please enter your password to proceed. Enter Keyword for Search.

Key events shows relevant news articles on days with large price movements. Imugene Ltd. IMU 4.

View Valuation. First Patient Recruited. It may take a few minutes to update your subscription details, during this time you will not be able to view locked content. Resend code. Please choose another Invalid password: must not contain more than 3 consecutive identical characters Invalid password: must not contain more than 3 consecutive sequential characters The password cannot contain the user name, given name, or family name. Connectivity and data. Date set for DXB clinical trial result [Jul]. Thank you. Future Growth. From selling in May, and tax loss selling in June recently, we look at how the cyclical nature of markets may present new investment opportunities to investors. Upgrade Today. Media centre. Market data is provided and copyrighted by Thomson Reuters and Morningstar.